These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2605797)

  • 1. Hypertension, the renin-angiotensin system and perindopril. First International Symposium on Perindopril. Paris, France, October 29, 1989.
    Clin Exp Hypertens A; 1989; 11 Suppl 2():459-623. PubMed ID: 2605797
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hypertension and the renin-angiotensin system. The role of perindopril. 1st international Coversyl symposium. Paris, 29 October 1988. Proceedings].
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():1-94. PubMed ID: 2505707
    [No Abstract]   [Full Text] [Related]  

  • 3. Hypertension and the renin-angiotensin system. The place of perindopril. Conclusions.
    Guedon J
    Clin Exp Hypertens A; 1989; 11 Suppl 2():619-23. PubMed ID: 2605802
    [No Abstract]   [Full Text] [Related]  

  • 4. Antihypertensive effect of perindopril: experimental pharmacology.
    Barthelmebs M; Devissaguet M; Imbs JL
    Clin Exp Hypertens A; 1989; 11 Suppl 2():471-86. PubMed ID: 2691126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of perindopril treatment on plasma and urine of kallikrein activity and the stable metabolite of prostaglandin E2 in patients with essential hypertension.
    Zacharieva S; Torbova S; Orbetzova M; Borissova AM; Andonova K; Sheitanova S
    Methods Find Exp Clin Pharmacol; 1996 Apr; 18(3):205-9. PubMed ID: 8738072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of perindopril on glucose and lipid metabolism in patients with mild-to-moderate essential hypertension and glucose intolerance.
    Uchida K; Azukizawa S; Kigoshi T; Nakano S; Kaneko M; Morimoto S; Matsui A
    Clin Ther; 1994; 16(3):466-70. PubMed ID: 7923313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of perindopril (prestarium) in arterial hypertension].
    Filatova NP
    Ter Arkh; 1995; 67(9):81-3. PubMed ID: 7495054
    [No Abstract]   [Full Text] [Related]  

  • 8. Preventing microalbuminuria in type 2 diabetes.
    Mauer M; Fioretto P
    N Engl J Med; 2005 Feb; 352(8):833-4; author reply 833-4. PubMed ID: 15736290
    [No Abstract]   [Full Text] [Related]  

  • 9. [Historical perspective of renin-angiotensin system blocking in the treatment of arterial hypertension].
    Coca A; Redón J
    Med Clin (Barc); 1996 Mar; 106(12):457-9. PubMed ID: 8656731
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].
    Rapezzi C; Ciliberti P; Graziosi M; Riva L
    Ital Heart J; 2005 Nov; 6 Suppl 7():40S-47S. PubMed ID: 16485516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study PROTECT (Perindopril Regression of Vascular Thickening). European Community Trial].
    Tarentini Trojani F
    Clin Ter; 1994 Nov; 145(11):411-2. PubMed ID: 7889727
    [No Abstract]   [Full Text] [Related]  

  • 12. Specific properties and effect of perindopril in controlling the renin-angiotensin system.
    Ferrari R; Pasanisi G; Notarstefano P; Campo G; Gardini E; Ceconi C
    Am J Hypertens; 2005 Sep; 18(9 Pt 2):142S-154S. PubMed ID: 16125051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The sympathetic and renin-angiotensin systems are complementary in blood pressure regulation].
    Sassard J; Barres C; Cerutti C; Julien C; Lo M; Gustin MP; Vincent M; Paultre CZ
    Bull Acad Natl Med; 1989 Dec; 173(9):1219-22; discussion 1223. PubMed ID: 2633862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical review of perindopril in the treatment of hypertension.
    Lerebours G; Antony I
    Can J Cardiol; 1994 Nov; 10 Suppl D():3D-7D. PubMed ID: 7954037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prospects for pharmacological effects on renin-angiotensin and sympathetic nervous systems in patients with arterial hypertension].
    Chikhladze NM
    Ter Arkh; 2000; 72(12):67-9. PubMed ID: 11201840
    [No Abstract]   [Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibitors and end-organ damage in heart failure.
    Sami M
    Can J Cardiol; 1999 May; 15 Suppl C():19C-23C. PubMed ID: 10380688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of type 2 diabetes mellitus due to antihypertensive treatment affecting renin-angiotensin system].
    Boucek P
    Vnitr Lek; 2006 Sep; 52(9):791-6. PubMed ID: 17091602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of the suppressed kidney renin level in the hypertensive transgenic rat TGR(mRen-2)27 by angiotensin converting enzyme inhibition.
    Tokita Y; Franco-Saenz R; Mulrow PJ
    Am J Hypertens; 1995 Oct; 8(10 Pt 1):1031-9. PubMed ID: 8845072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [First intention treatment of arterial hypertension. Effectiveness and safety of perindopril].
    Santoni JP; Bizot-Espiard JG; Brown C
    Ann Cardiol Angeiol (Paris); 1989 Sep; 38(7 Pt 2):477-82. PubMed ID: 2686525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perindopril (Coversyl)--a new ACE inhibitor. Perindopril--a review of its pharmacokinetics and clinical pharmacology.
    Reid JL; Macfadyen RJ; Lees KR
    S Afr Med J; 1991 Oct; Suppl():1-5. PubMed ID: 1925812
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.